|
1
|
Bendifallah S, Canlorbe G, Raimond E,
Hudry D, Coutant C, Graesslin O, Touboul C, Huguet F, Cortez A,
Daraï E and Ballester M: A clue towards improving the European
society of medical oncology risk group classification in apparent
early stage endometrial cancer? Impact of lymphovascular space
invasion. Br J Cancer. 110:2640–2646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colombo N, Creutzberg C, Amant F, Bosse T,
González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza
MR, et al: ESMO-ESGO-ESTRO consensus conference on endometrial
cancer: Diagnosis, treatment and follow-up. Ann Oncol. 27:16–41.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gilks CB, Oliva E and Soslow RA: Poor
interobserver reproducibility in the diagnosis of high-grade
endometrial carcinoma. Am J Surg Pathol. 37:874–881. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aghajanian C, Filiaci V, Dizon DS, Carlson
JW, Powell MA, Secord AA, Tewari KS, Bender DP, O'Malley DM,
Stuckey A, et al: A phase II study of frontline
paclitaxel/carboplatin/bevacizumab,
paclitaxel/carboplatin/temsirolimus, or
ixabepilone/carboplatin/bevacizumab in advanced/recurrent
endometrial cancer. Gynecol Oncol. 150:274–281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Makker V, Taylor MH, Aghajanian C, Oaknin
A, Mier J, Cohn AL, Romeo M, Bratos R, Brose MS, DiSimone C, et al:
Lenvatinib plus pembrolizumab in patients with advanced endometrial
cancer. J Clin Oncol. 38:2981–2992. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang TY, Li BL, Chang CC and Urano Y:
Acyl-coenzyme A: Cholesterol acyltransferases. Am J Physiol
Endocrinol Metab. 297:E1–E9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Danilo C, Gutierrez-Pajares JL, Mainieri
MA, Mercier I, Lisanti MP and Frank PG: Scavenger receptor class B
type I regulates cellular cholesterol metabolism and cell signaling
associated with breast cancer development. Breast Cancer Res.
15:R872013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paillasse MR, de Medina P, Amouroux G,
Mhamdi L, Poirot M and Silvente-Poirot S: Signaling through
cholesterol esterification: A new pathway for the cholecystokinin 2
receptor involved in cell growth and invasion. J Lipid Res.
50:2203–2211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tosi MR and Tugnoli V: Cholesteryl esters
in malignancy. Clin Chim Acta. 359:27–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mayengbam SS, Singh A, Pillai AD and Bhat
MK: Influence of cholesterol on cancer progression and therapy.
Transl Oncol. 14:1010432021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Antalis CJ, Arnold T, Rasool T, Lee B,
Buhman KK and Siddiqui RA: High ACAT1 expression in estrogen
receptor negative basal-like breast cancer cells is associated with
LDL-induced proliferation. Breast Cancer Res Treat. 122:661–670.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bemlih S, Poirier MD and El Andaloussi A:
Acyl-coenzyme A: Cholesterol acyltransferase inhibitor avasimibe
affect survival and proliferation of glioma tumor cell lines.
Cancer Biol Ther. 9:1025–1032. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song
B, Cheng L, Masterson TA, Liu X, Ratliff TL and Cheng JX:
Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT
activation underlies human prostate cancer aggressiveness. Cell
Metab. 19:393–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Gu D, Lee SS, Song B, Bandyopadhyay
S, Chen S, Konieczny SF, Ratliff TL, Liu X, Xie J and Cheng JX:
Abrogating cholesterol esterification suppresses growth and
metastasis of pancreatic cancer. Oncogene. 35:6378–6388. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ayyagari VN, Wang X, Diaz-Sylvester PL,
Groesch K and Brard L: Assessment of acyl-CoA cholesterol
acyltransferase (ACAT-1) role in ovarian cancer progression-an in
vitro study. PLoS One. 15:e02280242020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Gonzalo-Calvo D, López-Vilaró L,
Nasarre L, Perez-Olabarria M, Vázquez T, Escuin D, Badimon L,
Barnadas A, Lerma E and Llorente-Cortés V: Intratumor cholesteryl
ester accumulation is associated with human breast cancer
proliferation and aggressive potential: A molecular and
clinicopathological study. BMC Cancer. 15:4602015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ayyagari V, Li M, Pasman Z, Wang X, Louis
S, Diaz-Sylvester P, Groesch K, Wilson T and Brard L: Assessment of
the diagnostic and prognostic relevance of ACAT1 and CE levels in
plasma, peritoneal fluid and tumor tissue of epithelial ovarian
cancer patients-a pilot study. BMC Cancer. 22:3872022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Secord AA, Hasselblad V, Von Gruenigen VE,
Gehrig PA, Modesitt SC, Bae-Jump V and Havrilesky LJ: Body mass
index and mortality in endometrial cancer: A systematic review and
meta-analysis. Gynecol Oncol. 140:184–190. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miao R, Badger TC, Groesch K,
Diaz-Sylvester PL, Wilson T, Ghareeb A, Martin JA, Cregger M, Welge
M, Bushell C, et al: Assessment of peritoneal microbial features
and tumor marker levels as potential diagnostic tools for ovarian
cancer. PLoS One. 15:e02277072020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Piulats JM, Guerra E, Gil-Martín M,
Roman-Canal B, Gatius S, Sanz-Pamplona R, Velasco A, Vidal A and
Matias-Guiu X: Molecular approaches for classifying endometrial
carcinoma. Gynecol Oncol. 145:200–207. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cramer DW: The epidemiology of endometrial
and ovarian cancer. Hematol Oncol Clin North Am. 26:1–12. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Merritt MA and Cramer DW: Molecular
pathogenesis of endometrial and ovarian cancer. Cancer Biomark.
9:287–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Omsjø IH and Norum KR: Cholesterol
esterification in human secretory endometrium and in endometrial
cancer tissue. Demonstration of microsomal acyl-CoA-cholesterol
acyl-transferase (ACAT) activity. Acta Obstet Gynecol Scand.
64:473–476. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Odagiri T, Watari H, Hosaka M, Mitamura T,
Konno Y, Kato T, Kobayashi N, Sudo S, Takeda M, Kaneuchi M and
Sakuragi N: Multivariate survival analysis of the patients with
recurrent endometrial cancer. J Gynecol Oncol. 22:3–8. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sahoo SS, Zhang XD, Hondermarck H and
Tanwar PS: The emerging role of the microenvironment in endometrial
cancer. Cancers (Basel). 10:4082018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rana SV, Babu SG and Kocchar R: Usefulness
of ascitic fluid cholesterol as a marker for malignant ascites. Med
Sci Monit. 11:Cr136–Cr142. 2005.PubMed/NCBI
|
|
29
|
Tabas I: Consequences of cellular
cholesterol accumulation: Basic concepts and physiological
implications. J Clin Invest. 110:905–911. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li J, Qu X, Tian J, Zhang JT and Cheng JX:
Cholesterol esterification inhibition and gemcitabine
synergistically suppress pancreatic ductal adenocarcinoma
proliferation. PLoS One. 13:e01933182018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu L, Xu HX, Wang WQ, Wu CT, Chen T, Qin
Y, Liu C, Xu J, Long J, Zhang B, et al: Cavin-1 is essential for
the tumor-promoting effect of caveolin-1 and enhances its
prognostic potency in pancreatic cancer. Oncogene. 33:2728–2736.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee HJ, Li J, Vickman RE, Li J, Liu R,
Durkes AC, Elzey BD, Yue S, Liu X, Ratliff TL and Cheng JX:
Cholesterol esterification inhibition suppresses prostate cancer
metastasis by impairing the Wnt/β-catenin pathway. Mol Cancer Res.
16:974–985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scott CC, Vossio S, Vacca F, Snijder B,
Larios J, Schaad O, Guex N, Kuznetsov D, Martin O, Chambon M, et
al: Wnt directs the endosomal flux of LDL-derived cholesterol and
lipid droplet homeostasis. EMBO Rep. 16:741–752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Goad J, Ko YA, Kumar M, Jamaluddin MFB and
Tanwar PS: Oestrogen fuels the growth of endometrial hyperplastic
lesions initiated by overactive Wnt/β-catenin signalling.
Carcinogenesis. 39:1105–1116. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Meng F, Xu Y, Yang S, Xiao M, Chen
X and Lou G: Overexpression of Wnt7a is associated with tumor
progression and unfavorable prognosis in endometrial cancer. Int J
Gynecol Cancer. 23:304–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Coopes A, Henry CE, Llamosas E and Ford
CE: An update of Wnt signalling in endometrial cancer and its
potential as a therapeutic target. Endocr Relat Cancer. Aug
9–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Hanifi-Moghaddam P, Hanekamp EE,
Kloosterboer HJ, Franken P, Veldscholte J, van Doorn HC, Ewing PC,
Kim JJ, Grootegoed JA, et al: Progesterone inhibition of
Wnt/beta-catenin signaling in normal endometrium and endometrial
cancer. Clin Cancer Res. 15:5784–5793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoshioka S, King ML, Ran S, Okuda H,
MacLean JA II, McAsey ME, Sugino N, Brard L, Watabe K and Hayashi
K: WNT7A regulates tumor growth and progression in ovarian cancer
through the WNT/β-catenin pathway. Mol Cancer Res. 10:469–482.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hultsch S, Kankainen M, Paavolainen L,
Kovanen RM, Ikonen E, Kangaspeska S, Pietiäinen V and Kallioniemi
O: Association of tamoxifen resistance and lipid reprogramming in
breast cancer. BMC Cancer. 18:8502018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liscovitch M and Lavie Y: Multidrug
resistance: A role for cholesterol efflux pathways? Trends Biochem
Sci. 25:530–534. 2000. View Article : Google Scholar : PubMed/NCBI
|
